Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-09-08 00:00:00 ET · period of report 2023-09-06 · accession 0001209191-23-048820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-09-08 | 2023-09-06+ | KYNB | Graham Juan | CFO | F - Tax | $0.9782 | -1,807 | 190.4K | -0.9% | -$1,768 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-07 | F | D | 1,096 | $0.99 | 189,276 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |
| 2 | Common | Common Stock | 2023-09-06 | F | D | 711 | $0.96 | 190,372 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |